Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells $619,552.52 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 22,562 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $27.46, for a total value of $619,552.52. Following the transaction, the chief executive officer owned 591,656 shares of the company’s stock, valued at $16,246,873.76. This represents a 3.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Heartflow Trading Down 16.5%

HTFL opened at $22.49 on Friday. Heartflow, Inc. has a twelve month low of $22.46 and a twelve month high of $41.22. The company has a market cap of $1.92 billion and a price-to-earnings ratio of -12.43. The stock has a 50-day moving average price of $30.11.

Wall Street Analyst Weigh In

Several research analysts have recently commented on HTFL shares. Canaccord Genuity Group boosted their target price on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Stifel Nicolaus increased their target price on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Wells Fargo & Company began coverage on shares of Heartflow in a report on Wednesday, January 28th. They set an “overweight” rating and a $38.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $38.50.

Institutional Investors Weigh In On Heartflow

Several institutional investors have recently modified their holdings of the business. TFC Financial Management Inc. acquired a new position in Heartflow in the third quarter valued at approximately $40,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the 3rd quarter valued at $59,000. Strs Ohio bought a new position in shares of Heartflow in the 4th quarter worth $99,000. Staley Capital Advisers Inc. acquired a new stake in shares of Heartflow during the fourth quarter worth $204,000. Finally, Connable Office Inc. acquired a new stake in shares of Heartflow during the fourth quarter worth $220,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.